AL
CRDF icon

Airain Ltd’s Cardiff Oncology CRDF Stock Holding History

Airain Ltd’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-179
Closed -$70K – 830
2015
Q4 		$70K Buy
+179
New +$70.1K ﹤0.01% 783

Other funds holding CRDF

BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MWVC
Morgens Waterfall Vintiadis & Co New York $81.2M AUM 86.87% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Airain Ltd's CRDF Position: Q1 2016 in Review

Airain Ltd sold out of Cardiff Oncology (CRDF) in Q1 2016, closing a stake of 179 shares — an estimated $70K sold.

Airain Ltd first reported a position in CRDF in Q4 2015 and held it in 1 quarter. The position peaked at $70K in Q4 2015. 58 funds tracked by Wall St. Rank hold CRDF as of Q1 2016.

  • Airain Ltd reported no remaining Cardiff Oncology position as of Q1 2016 after selling out during the quarter.
  • Airain Ltd sold 179 Cardiff Oncology shares in Q1 2016, an estimated $70K.
  • Airain Ltd first reported a position in Cardiff Oncology in Q4 2015 and held it in 1 quarter.
  • Airain Ltd's Cardiff Oncology position peaked at $70K in Q4 2015.
  • 58 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2016.

Based on Airain Ltd's 13F filing for Q1 2016, filed 9 May 2016.